CoChat

Prevention of Transition From Incipient to Overt Nephropathy With Telmisartan in Patients With Type 2 Diabetes

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

To date, evidence for long-term renoprotection with angiotensin receptor blockers (ARBs) has come almost exclusively from Caucasian patients (1–3), despite Japanese people being at high risk of diabetic nephropathy and very susceptible to end-stage renal disease (4–6). We conducted the INNOVATION Study (Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy) to evaluate the efficacy of an ARB in preventing transition from microalbuminuria to overt nephropathy in Japanese patients (7). This study is the first large-scale clinical study to investigate prevention of overt diabetic nephropathy using an ARB in normotensive and hypertensive Japanese patients with type 2 diabetes. The randomized, multicenter, double-blind, placebo-controlled trial was performed in patients aged from 30 to 74 years with type 2 diabetes and urinary albumin-to-creatinine ratio (UACR) 100–300 mg/g and serum creatinine <1.5 mg/dl (men) and <1.3 mg/dl (women). Exclusion criteria included type 1 diabetes, age of diabetes onset <30 years, seated systolic blood pressure (SBP)/diastolic blood pressure (DBP) ≥180/100 mmHg, and definable chronic kidney disease …

Overview

Integrity signals

Registry

Crossref · 10.2337/dc06-1998

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 8 references

Cited by

See all 230

Metadata

Authors
Makino, H., Haneda, M., Babazono, T., Moriya, T., Ito, S., Iwamoto, Y., Kawamori, R., Takeuchi, M., Katayama, S., & for the INNOVATION Study Group
Affiliations
  • Okayama University (JP)
  • Asahikawa Medical University (JP)
  • Tokyo Women's Medical University (JP)
  • Kitasato University (JP)
  • Tohoku University (JP)
  • Juntendo University (JP)
  • Saitama Medical University (JP)
Venue
Diabetes Care
Published
2007-06-01
Volume
30
Issue
6
Pages
1577-1578
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2140563977
Cited by
230
References
8
Citations by year
2026: 5 · 2025: 7 · 2024: 5 · 2023: 14 · 2022: 8 · 2021: 8 · 2020: 12 · 2019: 3 · 2018: 7 · 2017: 11 · 2016: 8 · 2015: 14 · 2014: 14 · 2013: 17 · 2012: 21
FWCI
13.56
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
  • Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
Keywords
telmisartan, angiotensin receptor blockers, diabetic nephropathy, type 2 diabetes, microalbuminuria, renal protection, Japanese patients, hypertension, albumin-creatinine ratio
MeSH terms
Telmisartan, Adult, Aged, Albuminuria, Angiotensin-Converting Enzyme Inhibitors, Benzimidazoles, Benzoates, Diabetic Nephropathies, Double-Blind Method, Humans, Middle Aged, Placebos

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.